245
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Immunotherapy for brain tumors: quo vadis?

Pages 447-451 | Published online: 09 Jan 2014
 

Abstract

‘...the last 10 years has seen an increasing number of clinical trials involving immunomodulatory cytokines, dendritic cells, and gene therapy vectors, all of which have advanced our knowledge and understanding of brain tumor immunology.’

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.